Navigation Links
Genomic Health to Present at Two Upcoming Investor Conferences
Date:9/13/2010

REDWOOD CITY, Calif., Sept. 13 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in September:

  • Dean Schorno, senior vice president of Finance, will present at the Stifel Nicolaus Healthcare Conference 2010 on Friday, September 17 at 11:30 a.m. ET in Boston; and
  • Brad Cole, Genomic Health's Chief Operating Officer and Chief Financial Officer, will present at the JMP Securities Healthcare Conference on Monday, September 27 at 11:00 a.m. ET in New York City.

To access the live and subsequently archived webcasts of the presentations, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com. Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX(R) breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in ea
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
2. J. Craig Venter Institute Hosts Genomics Education Program for DC Metro Area Teachers
3. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
4. Sirius Genomics Announces Appointment of Senior Director of Business Development
5. SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
6. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
7. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
8. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
9. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
10. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
11. Trinean Reduces Volume and Time Requirements for Genomic DNA Quantification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils the ... Tin Can API combined with its own proprietary ... leading developer of training content and solutions for ... , Tin Can API is a cost-effective learning ... more accurately measure the Return on Education (ROE) ...
(Date:5/21/2013)... 2013 Alpha Source, Inc., a ... be exhibiting for the 13th consecutive year at ... (AAMI) 2013 Conference and Expo. The conference brings ... manufacture healthcare technologies. This year’s event will be ... , The three-day event draws over 1,500 ...
(Date:5/21/2013)... May 21, 2013 Clinverse, ... company for clinical trials, announced today it has ... LLC. Clinverse’s ClinPay® FLS eClinical commerce platform ... process. SpendMD ™, Aggregate Spend Solutions’ ... for tracking and reporting transfer of value at ...
(Date:5/21/2013)... Toronto, Canada (PRWEB) May 21, 2013 ... there is a strong push within the industry ... Development and Manufacturing Organizations and pharma companies often ... time frames. , Microtablets, developed in collaboration with ... how effective outsourcing can bring products to market ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... Incorporated (Nasdaq: VPHM ) was honored with ... Disorders (NORD) Annual Gala for its work in bringing ... rare and devastating disorder -- hereditary angioedema (HAE).HAE is ... a deficiency of C1 inhibitor, a human plasma protein. ...
... 2 Studies Evaluating KRX-0401 in Advanced Renal Cell Carcinoma, ... , NEW YORK, May 18 Keryx Biopharmaceuticals, ... four abstracts on KRX-0401 (Perifosine), the Company,s Akt-inhibitor for ... place at the 45th Annual Meeting of the American ...
... May 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ... American Society of Clinical Oncology (ASCO) Annual Meeting being ... related to our product candidates Stimuvax(R), PX-866 and PX-12 ... ASCO Web site, www.abstract.asco.org ., ...
Cached Biology Technology:ViroPharma Incorporated Honored by the National Organization for Rare Disorders 2ViroPharma Incorporated Honored by the National Organization for Rare Disorders 3ViroPharma Incorporated Honored by the National Organization for Rare Disorders 4ViroPharma Incorporated Honored by the National Organization for Rare Disorders 5Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3
(Date:5/21/2013)... a long time that some creatures evolve more quickly ... plants. But it may be that height plays a ... the U. S. National Evolutionary Synthesis Center. , ... the journal Nature Communications , Lanfear and colleagues ... from a database of global patterns in plant height ...
(Date:5/21/2013)... Wash. A new analysis shows that the nation,s ... of enough algae to produce up to 25 billion ... States, one-twelfth of the country,s yearly needs. , The ... resources that would be needed to grow significant amounts ... results were published in the May 7 issue of ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Single-cell transfection tool enables added control for biological studies 2
... MAWhen searching for long-lost treasure, sometimes all you need ... at the Marine Biological Laboratory,s (MBL) Josephine Bay Paul ... component the nucleolinus and confirm its role ... Anne Alliegro, and MBL visiting investigator Jonathan Henry of ...
... 2010 [Vienna, Austria] Sandra Roelofs, First Lady of ... Irakli Giorgobiani, Georgia,s Vice Minister of Labour, Health and ... declaration of the XVIII International AIDS conference (AIDS 2010) ... ) is a scientific statement seeking to improve community ...
... cell death, is essential to normal development, healthy ... dramatically transforms cellular structures but the limitations of ... structural reorganization a mystery. , Now, in research ... of Proceedings of the National Academy of ...
Cached Biology News:Rediscovery: MBL scientists confirm role for mysterious cell component, the nucleolinus 23 Georgian leaders sign Vienna Declaration, strengthen call for science-based drug policy 23 Georgian leaders sign Vienna Declaration, strengthen call for science-based drug policy 33 Georgian leaders sign Vienna Declaration, strengthen call for science-based drug policy 4How do cells die? Biophotonic tools reveal real-time dynamics in living color 2How do cells die? Biophotonic tools reveal real-time dynamics in living color 3
ERalpha (Ser 104/106)...
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Biology Products: